Innovation has “created a tailwind for the company that that we haven’t had in a long time,” Medtronic CEO Geoff Martha said at the 2025 JP Morgan Healthcare Conference. “These are growth-drivers ...

Get Wall Street's Hottest Chart Every Morning RBC Capital Markets says Vertex management is optimistic about the recently approved Alyftrek. They predict that most of the 6,000 patients who ...

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.

At the 43rd annual J.P. Morgan Healthcare Conference on Monday, Medtronic CEO Geoff Martha mixed in some breaking news with his usual pitch to investors. Just hours earlier, the Centers for ...

Five years ago, Medtronic executives set out to change the company culture and prioritize financial performance alongside innovation. The medtech giant centralized operations to lower costs, brought ...

SAN FRANCISCO—While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now received a European approval for what it describes as ...

BOSTON, January 12, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the ...

Investors including Covidien, now part of Medtronic, helped Fire1 get set up in 2014 and continued to fund the startup across a series of subsequent financing rounds. The support has enabled Fire1 to ...

2. Medtronic and Kuros Biosciences signed a strategic agreement to support sales of the MagnetOs bone graft technology. 3. SpineGuard and Omnia Medical extended their partnership and have their eyes ...

Vertex Pharmaceuticals is hoping to build upon its existing rare blood disease treatment portfolio, teaming up with Orna Therapeutics’ ReNAgade in efforts to develop next-gen gene therapies for ...

The Harmony transcatheter pulmonary valve (TPV) system [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + today announced CE mark approval for its Harmony transcatheter pulmonary valve (TPV ...